The Evolving Therapeutic Landscapes in Advanced Cervical and Endometrial Cancers

Access Course

 

The Evolving Therapeutic Landscapes in Advanced Cervical and Endometrial CancersRead about the latest advances in immuno-and targeted therapies for treating patients with advanced cervical and endometrial cancers.

 

This activity is intended for hematologist/oncologists, obstetrics/gynecologists, and other healthcare professionals who treat patients with cervical and endometrial cancers.

 

The goal of this activity is to increase understanding of current standards and new strategies for the treatment of advanced cervical and endometrial cancers.

 

Learning Objectives:

  • Have increased knowledge regarding the current standard of care for patients with advanced cervical and endometrial cancers.
  • Have increased knowledge regarding the clinical trial safety and efficacy data for novel therapies, both alone and in combination with other novel agents, in advanced cervical and endometrial cancers.
  • Demonstrate greater confidence in their ability to interpret clinical trial data of novel agents in order to understand the impact on the treatment paradigm in advanced cervical and endometrial cancers.

 

Approximate Time to Complete: 60 minutes

 

Credit Available: April 10, 2020 - April 10, 2021

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png     

Medscape_EDU-RGB-2x-300.png

 

Additional Resources for Clinicans from SITC:

 

sitc-cig-rgb.png

 

 

 

View Available Guidelines Here.

Accreditation Council for Continuing Medical Education and ABIM Maintenance of Certification
AMA PRA Category 1 Credit(s)™ / ABIM Maintenance of Certification Part 2 Credit: 1.00
Accreditation Council for Continuing Medical Education (MD/DO)
AMA PRA Category 1 Credit(s)™: 1.00